LRSVX
Price
$21.21
Change
-$0.87 (-3.94%)
Updated
Dec 18 closing price
VSIAX
Price
$85.23
Change
-$3.35 (-3.78%)
Updated
Dec 18 closing price
Ad is loading...

LRSVX vs VSIAX

Header iconLRSVX vs VSIAX Comparison
Open Charts LRSVX vs VSIAXBanner chart's image
Lord Abbett Small Cap Value R6
Price$21.21
Change-$0.87 (-3.94%)
VolumeN/A
CapitalizationN/A
Vanguard Small Cap Value Index Admiral
Price$85.23
Change-$3.35 (-3.78%)
VolumeN/A
CapitalizationN/A
LRSVX vs VSIAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
LRSVX vs. VSIAX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LRSVX is a Hold and VSIAX is a Hold.

FUNDAMENTALS
Fundamentals
VSIAX has more cash in the bank: 63B vs. LRSVX (429M). VSIAX pays higher dividends than LRSVX: VSIAX (2.01) vs LRSVX (0.26). LRSVX was incepted earlier than VSIAX: LRSVX (9 years) vs VSIAX (13 years). LRSVX is a more actively managed with annual turnover of: 34.00 vs. VSIAX (16.00). LRSVX has a lower initial minimum investment than VSIAX: LRSVX (0) vs VSIAX (3000). VSIAX annual gain was more profitable for investors over the last year : 16.23 vs. LRSVX (11.36). VSIAX return over 5 years is better than : 52.83 vs. LRSVX (16.09).
LRSVXVSIAXLRSVX / VSIAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence9 years13 years-
Gain YTD9.45615.03163%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets429M63B1%
Annual Yield % from dividends0.262.0113%
Returns for 1 year11.3616.2370%
Returns for 3 years11.2520.6754%
Returns for 5 years16.0952.8330%
Returns for 10 yearsN/A105.65-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ALTO1.470.04
+2.80%
Alto Ingredients
ADXN7.80-0.05
-0.64%
Addex Therapeutics Ltd
DCOM33.96-0.84
-2.41%
Dime Community Bancshares
CAVA123.37-3.42
-2.70%
CAVA Group
EWTX30.17-2.52
-7.71%
Edgewise Therapeutics